Peptide science has enjoyed a fruitful period with advances made in areas such as novel therapeutic approaches, faster manufacturing, improved diagnostics, and sustainable industrial compounds. Here we summarize some notable, peer-reviewed scientific publications for academic researchers or those looking to purchase peptides for laboratory purposes. A quick caveat: the majority of the results presented below were achieved in preclinical or proof-of-concept studies and not yet in clinical trials.
Therapeutic Developments
The growing problem of bacterial antibiotic resistance fuels research into antimicrobial peptides (AMPs). One interesting development was that scientists explored the human proteome to find encoded peptide antibiotics and revealed thousands of “encrypted” peptide antibiotics, which are able to kill resistant strains of bacteria by destroying their cell membrane and exhibit anti-infective activity in mice without allowing pathogens to develop any resistance to the peptides, in contrast to classical antibiotics (Torres et al., Nature Biomedical Engineering, 2022). Further, reviews on AMPs’ ability to kill ESKAPE multidrug-resistant pathogens can help understand the current position of these candidates on the market and their limitations in terms of stability, toxicity, and expensive production (BioDrugs, 2025).
On the metabolic side, peptide-based GLP-1 receptor agonists have proven to be one of the most clinically relevant peptides. Their role in the treatment of type 2 diabetes and obesity is well–established, and current research is focused on developing long-acting, stable, and convenient analogs (Viljoen & Bain, Endocrinology and Metabolism, 2023).
Peptide Synthesis and Discovery
The advancements in peptide synthesis are primarily responsible for this progress, as growing technological maturity decreases the costs associated with the creation of long and complicated molecules. The fast-flow solid-phase peptide synthesis methodology has been highlighted as a particularly promising technique – according to the article, it can produce an amide bond within 7 seconds and each additional amino acid takes approximately 40 seconds, with crude purities and yields being on par with traditional batch synthesis (Mijalis et al., Nature Chemical Biology, 2017). Another automated system that builds peptides by assembling their chains allows obtaining linear molecules consisting of up to 164 amino acids within a few hours, with their folded forms demonstrating properties comparable to naturally-synthesized ones (Hartrampf et al., Science, 2020). The ability to synthesize peptides rapidly and reliably several times per day transforms the practical limits of what can be achieved within a research facility, thereby enabling both academic and commercial enterprises to pursue ambitious projects.
Diagnostics and Imaging
Peptide-based targeting is another area that has seen significant recent improvements. In particular, cyclic peptides can be equipped with fluorescent labels, such as near-infrared dyes, to form targeting molecular agents capable of binding tumor-specific domains and demonstrating efficacy in real-time optical imaging in an in vivo setting, offering reduced background staining (Mendive-Tapia et al., Peptide Science, 2021). The value of such developments is obvious, as they facilitate both basic research and the creation of clinical assays several years later.
Peptides in Industry and Biotechnology
The use of peptides is not limited to medicine only. A recent proof of concept study involved the creation of marine coatings using natural cyclic peptides (portoamides) which were isolated from cyanobacteria. The peptide-coatings prevented the settlement of mussel larvae, prevented biofilm formation and performed better than a commercially available biocide even under real marine conditions without much risk for marine ecosystems (Gonçalves et al., Trends in Biotechnology, 2026). This seems like a promising alternative to the biocides-filled antifouling paints currently dominating the market.
Conclusion
Summing up all of this work it becomes clear how diverse the uses of peptides became – from new antibiotics to already established metabolic therapies, imaging to sustainable material science. With more advanced technology becoming available at the same time, we may be looking at an acceleration of discoveries in this area. Since the majority of these results are pre-clinical, it will be best to go to the source articles for more details.
Resources
- Torres et al., “Mining for encrypted peptide antibiotics in the human proteome,” Nature Biomedical Engineering (2022): https://www.nature.com/articles/s41551-021-00801-1
- “Advances of Antimicrobial Peptides in the Treatment of Multidrug-Resistant Bacteria,” BioDrugs (2025): https://link.springer.com/article/10.1007/s40259-025-00740-2
- Viljoen & Bain, “Glucagon-Like Peptide 1 Therapy: From Discovery to Type 2 Diabetes and Beyond,” Endocrinology and Metabolism (2023): https://www.e-enm.org/journal/view.php?number=2366
- Mijalis et al., “A fully automated flow-based approach for accelerated peptide synthesis,” Nature Chemical Biology (2017): https://www.nature.com/articles/nchembio.2318
- Hartrampf et al., “Synthesis of proteins by automated flow chemistry,” Science (2020): https://www.science.org/doi/10.1126/science.abb2491
- Mendive-Tapia et al., “Fluorescent cyclic peptides for cell imaging,” Peptide Science (2021): https://onlinelibrary.wiley.com/doi/10.1002/pep2.24181
- Gonçalves et al., “Engineered coatings containing cyclic peptides from cyanobacteria delay the development of a stable macrofouling community,” Trends in Biotechnology (2026): https://www.cell.com/trends/biotechnology/fulltext/S0167-7799(25)00492-5